Trimethoprim-sulfamethoxazole. II. Clinical studies.
D001424:Bacterial Infections / Q000188:drug therapy; D003365:Costs and Cost Analysis; D004338:Drug Combinations; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D005260:Female; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy; D008288:Malaria / Q000188:drug therapy; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012749:Sexually Transmitted Diseases / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole